SUBSCRIBE
SUBSCRIBE

Texas

LATEST FROM BIOSPACE
Drug Development
Once Suspect Protein Found to Promote DNA Repair, Prevent Cancer in M. D. Anderson Cancer Center Study
July 24, 2008
 · 
1 min read
Policy
New Guidelines on Infant Stroke Released by American Heart Association/American Stroke Association
July 18, 2008
 · 
1 min read
Lone Star Bio
Genetic Variation Increases HIV Risk in Africans, Wilford Hall United States Air Force Medical Center, San Antonio Military Medical Center, and University of Texas Health Science Center Study Finds
July 17, 2008
 · 
1 min read
Lone Star Bio
University of Texas Pathologists Believe they have Pinpointed Achilles Heel of HIV
July 16, 2008
 · 
1 min read
Drug Development
Warfarin Safer than Heparin for Some Strokes, University of Texas Health Science Center Study Suggests
July 15, 2008
 · 
1 min read
Drug Development
New Protein Linked to the Spread of Prostate Cancer to the Bones in M. D. Anderson Cancer Center Study
July 14, 2008
 · 
1 min read
Drug Development
Previously Found Cancer-Promoting Protein in Animal Model Shown to Act as Tumor Suppressor in Cell Culture, UT Southwestern Medical Center Study
July 9, 2008
 · 
1 min read
Lone Star Bio
Kidney Cancer Vaccine Shows No Boost in Survival in M. D. Anderson Cancer Center Study
July 7, 2008
 · 
1 min read
Lone Star Bio
‘Smart’ Materials Developed at University of Texas Get Smarter with Ability to Better Control Shape and Size
July 7, 2008
 · 
1 min read
Drug Development
Amgen’s (JOBS) Tumor-Starving Pill Helps Thyroid Cancer: M. D. Anderson Cancer Center Study
July 3, 2008
 · 
1 min read
Load More
PRESS RELEASES
Press Releases
AustinPx Expands KinetiSol™ Technology Commercial Access through Thermo Fisher Scientific Collaboration
June 30, 2026
 · 
4 min read
Press Releases
FibroBiologics to Participate in Fireside Chat at H.C. Wainwright 4th Annual Cell Therapy Virtual Conference
June 30, 2026
 · 
1 min read
Press Releases
Moleculin Reports Positive Phase 2/3 MIRACLE Interim Results, With Annamycin Complete Remission Rates 3-fold Greater than Control
June 30, 2026
 · 
9 min read
Press Releases
Plus Therapeutics Provides Mid-Year Business Update Including Corporate Rebranding
June 30, 2026
 · 
10 min read
Press Releases
FibroBiologics Announces Closing of up to $9.0 Million Private Placement Priced At-the-Market Under Nasdaq Rules
June 30, 2026
 · 
5 min read
Press Releases
Texas Biomed and Flyttr partner to advance next-generation solutions for the invasive New World screwworm
June 29, 2026
 · 
3 min read
Press Releases
Natera and Aveta Biomics Announce Strategic Partnership Supporting Global Phase 3 Registrational Trial of APG-157 in Head and Neck Cancer
June 29, 2026
 · 
6 min read
Press Releases
Decoy Therapeutics, Inc. Announces Up to $21 Million Private Placement Financing
June 28, 2026
 · 
5 min read
Press Releases
FibroBiologics Announces up to $9.0 Million Private Placement Priced At-the-Market Under Nasdaq Rules
June 26, 2026
 · 
6 min read
Press Releases
Medicenna Therapeutics Reports Fiscal Year 2026 Financial Results and Operational Highlights
June 26, 2026
 · 
11 min read
Load More